Immunogenic Chemotherapy Sensitizes Renal Cancer to Immune Checkpoint Blockade Therapy in Preclinical Models

Por Cui, Shujin
Publicado no Med Sci Monit (2017)

Therapeutic Bronchoscopy for Malignant Central Airway Obstruction: Success Rates and Impact on Dyspnea and Quality of Life

Por Ost, David E., Ernst, Armin, Grosu, Horiana B., Lei, Xiudong, Diaz-Mendoza, Javier, Slade, Mark, Gildea, Thomas R., Machuzak, Michael S., Jimenez, Carlos A., Toth, Jennifer, Kovitz, Kevin L., Ray, Cynthia, Greenhill, Sara, Casal, Roberto F., Almeida, Francisco A., Wahidi, Momen M., Eapen, George A., Feller-Kopman, David, Morice, Rodolfo C., Benzaquen, Sadia, Tremblay, Alain, Simoff, Michael
Publicado no Chest (2015)

A Possible New Multiple Endocrine Neoplasia Mutation in a Patient with a Prototypic Multiple Endocrine Neoplasia Presentation

Por Buzzola, Rino, Kurukulasuriya, Lilamani Romayne, Touza, Mariana, Litofsky, Norman S., Brietzke, Stephen, Sowers, James R.
Publicado no Cardiorenal Med (2016)

Increased Risk of Additional Cancers Among Patients with Gastrointestinal Stromal Tumors: A Population-Based Study

Por Murphy, James D., Ma, Grace L., Baumgartner, Joel M., Madlensky, Lisa, Burgoyne, Adam M., Tang, Chih-Min, Martinez, Maria Elena, Sicklick, Jason K.
Publicado no Cancer (2015)

Challenges and developing solutions for increasing the benefits of IL-2 treatment in tumor therapy

Por Skrombolas, Denise, Frelinger, John G.
Publicado em 2014

The Effect of Sirolimus on Prostate-Specific Antigen (PSA) Levels in Male Renal Transplant Recipients Without Prostate Cancer

Por Chamie, K., Ghosh, P. M., Koppie, T. M., Romero, V., Troppmann, C., deVere White, R. W.
Publicado no Am J Transplant (2008)

Inhibitory Effect of Ursolic Acid on Proliferation and Migration of Renal Carcinoma Cells and Its Mechanism

Por Xiao Lyu, Xuhui Zhang, Libin Sun, Jingqi Wang, Dongwen Wang
Publicado em 2022-01-01

Naptumomab Estafenatox: Targeted Immunotherapy with a Novel Immunotoxin

Por Eisen, Tim, Hedlund, Gunnar, Forsberg, Göran, Hawkins, Robert
Publicado em 2014

Determinants of IL-6 levels during HIV infection

Por Borges, Álvaro H, O'Connor, Jemma L, Phillips, Andrew N, Rönsholt, Frederikke F, Pett, Sarah, Vjecha, Michael J, French, Martyn A, Lundgren, Jens D
Publicado no J Int AIDS Soc (2014)

FDG-PET as a predictive biomarker for therapy with everolimus in metastatic renal cell cancer

Por Chen, James L, Appelbaum, Daniel E, Kocherginsky, Masha, Cowey, Charles L, Kimryn Rathmell, Wendy, McDermott, David F, Stadler, Walter M
Publicado em 2013

Prevalence and survival prognosis of prostate cancer in patients with end-stage renal disease: a...

Por Kim, Sung Han, Joung, Jae Young, Suh, Yoon Seok, Kim, Young Ae, Hong, Jin Hyuk, Kuark, Tong Sun, Lee, Eun Sook, Lee, Kang Hyun
Publicado no Oncotarget (2017)

Thyroid-Like Follicular Carcinoma of the Kidney in a Patient with Skull and Meningeal Metastasis: A Unique Case Report and Review of the Literature

Por Dong, Liang, Huang, Jiayu, Huang, Luke, Shi, Oumin, Liu, Qiang, Chen, Haige, Xue, Wei, Huang, Yiran
Publicado no Medicine (Baltimore) (2016)

Clinical and Prognostic Effect of Plasma Fibrinogen in Renal Cell Carcinoma: A Meta-Analysis

Por Tian, Yuejun, Hong, Mei, Jing, Suoshi, Liu, Xingchen, Wang, Hanzhang, Wang, Xinping, Kaushik, Dharam, Rodriguez, Ronald, Wang, Zhiping
Publicado no Biomed Res Int (2017)

Long-term outcomes and propensity score matching analysis: rectal cancer resection for patients with elevated preoperative risk

Por Feng, Hao, Schiergens, Tobias S., Mao, Zhi-hai, Zhao, Jingkun, Shen, Xiaohui, Lu, Ai-Guo, Thasler, Wolfgang E.
Publicado no Oncotarget (2016)

Nivolumab in Renal Cell Carcinoma: Current Trends and Future Perspectives

Por Ochoa, Cesar E., Joseph, Richard W.
Publicado no J Kidney Cancer VHL (2018)

Abnormal methylation status of FBXW10 and SMPD3, and associations with clinical characteristics in clear cell renal cell carcinoma

Por WANG, JINYOU, LI, JIAN, GU, JUN, YU, JIAN, GUO, SHICHENG, ZHU, YAO, YE, DINGWEI
Publicado no Oncol Lett (2015)

Specific immunotherapy in renal cancer: a systematic review

Por Hirbod-Mobarakeh, Armin, Gordan, Hesam Addin, Zahiri, Zahra, Mirshahvalad, Mohammad, Hosseinverdi, Sima, Rini, Brian I., Rezaei, Nima
Publicado no Ther Adv Urol (2016)

Comparison of Four Bleeding Risk Scores to Identify Rivaroxaban‐treated Patients With Venous Thromboembolism at Low Risk for Major Bleeding

Por Kline, Jeffrey A., Jimenez, David, Courtney, D. Mark, Ianus, Juliana, Cao, Lynn, Lensing, Anthonie W.A., Prins, Martin H., Wells, Philip S.
Publicado no Acad Emerg Med (2016)

Venous Thromboembolism Risk in Patients With Locoregional Urothelial Tract Tumors

Por Ramos, Jorge D., Wingate, Jonathan T., Gulati, Roman, Plimack, Elizabeth R., Harshman, Lauren C., Powles, Thomas, Crabb, Simon J., Niegisch, Guenter, Bellmunt, Joaquim, Ladoire, Sylvain, De Giorgi, Ugo, Hussain, Syed, Alva, Ajjai S., Baniel, Jack, Agarwal, Neeraj, Rosenberg, Jonathan E., Vaishampayan, Ulka N., Galsky, Matthew D., Yu, Evan Y.
Publicado no Clin Genitourin Cancer (2017)

Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E...

Por Haas, Naomi B, Manola, Judith, Uzzo, Robert G, Flaherty, Keith T, Wood, Christopher G, Kane, Christopher, Jewett, Michael, Dutcher, Janice P, Atkins, Michael B, Pins, Michael, Wilding, George, Cella, David, Wagner, Lynne, Matin, Surena, Kuzel, Timothy M, Sexton, Wade J, Wong, Yu-Ning, Choueiri, Toni K, Pili, Roberto, Puzanov, Igor, Kohli, Manish, Stadler, Walter, Carducci, Michael, Coomes, Robert, DiPaola, Robert S
Publicado no Lancet (2016)